Podcasts about educational grant

MARSHA COTTRELL (b. 1964) lives and works in Brooklyn, NY. Cottrell was educated at The University of North Carolina at Chapel Hill (MFA) and Tyler School of Art (BFA). Cottrell is a recipient of the 2013 Louis Comfort Tiffany Foundation, Biennial Award; the 2007 Pollock-Krasner Foundation, Fellowship Grant in Drawing; the 2004 Harvestworks Digital Media Arts Center, Educational Grant; the 2003 New York Foundation for the Arts, Fellowship Grant in Drawing; the 2001 John Simon Guggenheim Memorial Foundation, Fellowship; the 1999 New York Foundation for the Arts, Fellowship Grant in Digital Arts; and the 1999 Marie Walsh Sharpe Art Foundation, Space Program. Cottrell has had solo exhibitions at Anthony Meier Fine Arts, San Francisco (2016); Eleven Rivington (2015), New York, NY; g-module, Paris, France (2003); Henry Urbach Architecture, New York, NY (2003); Gaga, New York, NY (2000), among others. Group exhibitions include Gray Matters, organized by Michael Goodson, Wexner Center for the Arts, Columbus, OH; Worlding: Lucas Blalock, Marsha Cottrell, Ben Hagari, Ajay Kurian, and Hayal Pozanti, organized by Mia Curran, University of Western Michigan, 2017; One Third White, Kunst im Tunnel (KIT), Dusseldorf, Germany, 2013; and Field Conditions, San Francisco Museum of Modern Art, San Francisco, CA, 2012. Selected public collections include The Museum of Modern Art, New York, NY; The Morgan Library and Museum, New York, NY; The National Gallery of Art, Washington, D.C.; Philadelphia Museum of Art, Philadelphia, PA; Pollock Gallery, Southern Methodist University, Dallas, TX; and San Francisco Museum of Modern Art, CA. Brian met up with Marsha at her solo show to talk about quiet and light and more.

Host: Alan S. Brown, MD, FNLA Guest: Allan Sniderman, MD Risk is calculated by a variety of algorithms, all of which produce an estimate for that individual based on age, gender, cholesterol, blood pressure, and smoking history. The estimate is critical to clinical decision-making, but how accurate is it? Host Dr. Alan Brown welcomes Dr. Allan Sniderman, Edwards Professor of Cardiology at McGill University, to discuss why we should pay more attention to the causes, and less to the risks, of cardiovascular disease. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Medication Adherence: is it the Achilles Heel in your therapies for patients with dyslipidemia? Dr. Lynne Braun, nurse practitioner in the Preventive Cardiology Center and the Heart Center for Women, and Professor in the Department of Adult Health Nursing at the Rush College of Nursing in Chicago, targets three critical barriers to lipid medication adherance: weak patient-provider relationships, health illiteracy, and poor health care transitions after hospital discharge. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Dr. Alan Brown welcomes Dr. Peter Jones, Associate Professor of Medicine and Atherosclorosis/Lipidology at Baylor College of Medicine in Houston, TX. They review special populations in the treatment of dyslipidemia, including Asians, women, elderly patients, and the immune-compromised. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Guest: Keith Ferdinand, MD Host Dr. Alan Brown is joined by Dr. Keith C. Ferdinand, Professor at Tulane University School of Medicine in New Orleans, Louisiana. Dr. Ferdinand reviews the etiologies, diagnostic challenges, and management considerations for selective cardiac health issues prevalent in African American populations, from hypertension to coronary arterial calcium plaques to lipid levels. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA One of the most recurrent questions that cardiologists and lipidologists face in daily practice is how to best approach the elderly patient with dyslipidemia. Joining Dr. Alan Brown for special considerations in this population and guideline-based recommendations for management is Joyce Ross, certified registered nurse practitioner, clinical lipid specialist, and President-Elect of the National Lipid Association. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Host Dr. Alan Brown welcomes Dr. Don Wilson, Endocrinologist at Cook Children's Health Care System, Fort Worth, Texas. Dr. Wilson will review dyslipidemia in children and adolescent patients. Key points of their discussion will cover the association between abnormal lipid levels in children and an increased lifetime risk of atherosclerotic CVD, as well as, the CVD risk factors present in children and how it tracks from childhood to adulthood. Supported by an Educational Grant from AstraZeneca. Supported by an Educational Grant from AstraZeneca. - See more at: https://reachmd.com/programs/lipid-luminations/million-hearts-initiative-dr-janet-wright-executive-director/7439/#sthash.aVHL9OOn.dpuf Supported by an Educational Grant from AstraZeneca. - See more at: https://reachmd.com/programs/lipid-luminations/million-hearts-initiative-dr-janet-wright-executive-director/7439/#sthash.aVHL9OOn.dpuf

Host: Alan S. Brown, MD, FNLA Guest: Janet Wright, MD Heart disease and stroke are two of the leading causes of death in the United States. The Department of Health and Human Services, with several key partners, launched the Million Hearts national public-private initiative. Million Hearts aims to prevent one million heart attacks and strokes over five years through behavioral changes and clinical interventions. Host Dr. Alan Brown welcomes Dr. Janet Wright, Executive Director of Million Hearts in Washington, DC. Supported by an Educational Grant from AstraZeneca.

Host: Prathima Setty, MD Issues of vaginal health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy. According to the US Census Bureau there are nearly 46M women between the ages of 50 and 80, and over 2.8M breast cancer survivors. Existing treatments for post-menopause vaginal health can be time intensive or messy, or contraindicated for health reasons. They also can have numerous side-effects and offer only marginal improvement -- according to a doctor associated with the study. Host Dr. Prathima Setty welcomes Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH. Dr. Karram will share preliminary findings from a trail evaluating laser treatment on post-menopausal women and breast cancer survivors experiencing vaginal health issues. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

The Park Family

Host: Prathima Setty, MD Issues of vaginal health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy. According to the US Census Bureau there are nearly 46M women between the ages of 50 and 80, and over 2.8M breast cancer survivors. Existing treatments for post-menopause vaginal health can be time intensive or messy, or contraindicated for health reasons. They also can have numerous side-effects and offer only marginal improvement -- according to a doctor associated with the study. Host Dr. Prathima Setty welcomes Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH. Dr. Karram will share preliminary findings from a trail evaluating laser treatment on post-menopausal women and breast cancer survivors experiencing vaginal health issues. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

Host: Prathima Setty, MD Issues of vaginal health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy. According to the US Census Bureau there are nearly 46M women between the ages of 50 and 80, and over 2.8M breast cancer survivors. Existing treatments for post-menopause vaginal health can be time intensive or messy, or contraindicated for health reasons. They also can have numerous side-effects and offer only marginal improvement -- according to a doctor associated with the study. Host Dr. Prathima Setty welcomes Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH. Dr. Karram will share preliminary findings from a trail evaluating laser treatment on post-menopausal women and breast cancer survivors experiencing vaginal health issues. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

Host: Prathima Setty, MD Issues of vaginal health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy. According to the US Census Bureau there are nearly 46M women between the ages of 50 and 80, and over 2.8M breast cancer survivors. Existing treatments for post-menopause vaginal health can be time intensive or messy, or contraindicated for health reasons. They also can have numerous side-effects and offer only marginal improvement -- according to a doctor associated with the study. Host Dr. Prathima Setty welcomes Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH. Dr. Karram will share preliminary findings from a trail evaluating laser treatment on post-menopausal women and breast cancer survivors experiencing vaginal health issues. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

Host: Prathima Setty, MD Issues of vaginal health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy. According to the US Census Bureau there are nearly 46M women between the ages of 50 and 80, and over 2.8M breast cancer survivors. Existing treatments for post-menopause vaginal health can be time intensive or messy, or contraindicated for health reasons. They also can have numerous side-effects and offer only marginal improvement -- according to a doctor associated with the study. Host Dr. Prathima Setty welcomes Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH. Dr. Karram will share preliminary findings from a trail evaluating laser treatment on post-menopausal women and breast cancer survivors experiencing vaginal health issues. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

Host: Prathima Setty, MD What are the benefits and harms of screening women for breast cancer? How often should we screen our patients? Are there technological advancements to help our patients live better and longer? Dr. Prathima Setty welcomes Dr. Russell P. Harris, Professor of Medicine and Adjunct Professor of Epidemiology at University of North Carolina, Chapel Hill, NC. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

Host: Prathima Setty, MD What are the benefits and harms of screening women for breast cancer? How often should we screen our patients? Are there technological advancements to help our patients live better and longer? Dr. Prathima Setty welcomes Dr. Russell P. Harris, Professor of Medicine and Adjunct Professor of Epidemiology at University of North Carolina, Chapel Hill, NC. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

Host: Prathima Setty, MD What are the benefits and harms of screening women for breast cancer? How often should we screen our patients? Are there technological advancements to help our patients live better and longer? Dr. Prathima Setty welcomes Dr. Russell P. Harris, Professor of Medicine and Adjunct Professor of Epidemiology at University of North Carolina, Chapel Hill, NC. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program.

Host: Alan S. Brown, MD, FNLA Dr. Alan Brown welcomes Dr. Daniel J. Rader, Cooper-McLure Professor of Medicine and Pharmacology and Chief of the Division of Translational Medicine and Human Genetics at the Perelman School of Medicine at the University of Pennsylvania. Their discussion focuses on the clinical diagnosis, genetic complexity and prevalence of HoFH while exploring the current and novel modalities available to help HoFH patients achieve their LDL goals. Produced in Partnership with Supported by an Educational Grant from